INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.

  • Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly accelerating your molecule from development to commercialization.

  • Clinical trials must accommodate operational challenges and changes in the market, which includes a sponsor's ability to forecast site activation, monitor resources, and track competitive activity.

  • With 80% of trials failing to enroll patients on time, improved collaboration between sites and sponsors is essential to enhance study startup.

  • Learn about how this participant-friendly technology ensures efficient and secure payments, enhancing the clinical trial experience for all involved.